CVR 41330619Private limited company (ApS)Oplagring og opbevaring (521000)København KFounded 27 Apr 2020
Employees
1
CVR registry, Aug 2026
0 (0%) over 12 months
Result
-537.5K
DKK, annual report 2025
Equity
-11.6M
DKK, annual report 2025
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Sentry BioPharma Services ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexSentry BioPharma Services, Inc.100% of capital and votes, since 27 Apr 2020
Timothy Jon Mitchellsince 27 Apr 2020
William Maxwell Tuttlesince 14 Feb 2023
Equity was negative at 31 Dec 2025: -11.6M DKK. Dandex estimate, computed 27 Oct 2026.
100% of capital and votessince 27 Apr 2020
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
27 Apr 2020 to 27 Oct 2026.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating profit | -776 | -3,006 | -3,797 | -2,406 | -2,442 |
| Result for the year | -1,056 | -2,821 | -3,615 | -3,276 | -538 |
| Equity | -1,378 | -4,199 | -7,814 | -11,090 | -11,627 |
| Total assets | 3,079 | 2,695 | 3,574 | 4,647 | 14,599 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 0 |
| Credit metrics (Dandex calculations) | |||||
| EBITDA | Not reportednote 1 | -2,187 | Not reportednote 1 | Not reportednote 1 | -1,998 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -167note 2 | -113note 2 | -350note 2 | -321note 2 | -1,715note 2 |
| NIBD incl. group and owner balances (NIBD inkl. koncern- og ejermellemværender) | 4,133note 2 | 6,527note 2 | 10,257note 2 | 13,140note 2 | 20,301note 2 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 26 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 15 Jul 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 12 Jul 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 10 Jul 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 29 Jun 2022
Sentry BioPharma Services ApS has changed ownership. A new strategy and new needs can be expected.
Signal, a Dandex estimate. Lapses 28 Jan 2027.
Sentry BioPharma Services ApS has moved to a new address, with a potential need for new suppliers.
Signal, a Dandex estimate. Lapses 29 Dec 2026.
1 registered in CVR.
P-number 1025787966August Bournonvilles Passage 1, 1055 København K
No other current company drawn.
No other current company drawn.
